🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CEDRN: Opioid Registry

Recruitingn/aAges any - anyAllUniversity of British Columbia
NCT07466784 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Unregulated opioids remain a leading driver of preventable mortality and potential years of life lost in Canada. Emergency departments (EDs)-open 24/7 and frequently accessed by people who use drugs-offer critical opportunities to reverse toxicity, mitigate harm, and initiate treatment. Yet, high quality evidence to guide ED care for patients with opioid poisoning and concomitant opioid dependence or opioid use disorder is limited. The investigators aim to establish a pan Canadian registry of patients presenting to EDs with opioid poisoning to generate timely, practice informing evidence. The investigators will create the Canadian Emergency Department Research Network (CEDRN) Opioid Registry across participating EDs nationwide. Using automated screening of electronic health records (EHRs), the investigators will identify consecutive patients of all ages with suspected or confirmed opioid

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. All patients who arrive at the emergency department with the following emergency department discharge diagnosis: * Percocet Overdose * Oxycontin Overdose * Oxycodone Overdose * Opioid Overdose or Intoxication * Methadone Overdose * Heroin Overdose * Fentanyl Overdose * Codeine Overdose * Carfentanil Overdose * Opioid Withdrawal 2. All patients who arrive at the emergency department who had the following medication ordered in the present visit or previous hospital visits in the past 2 years: * Buprenorphine * Buprenorphine-naloxone * Methadone - Past ED or IP encounter * Kadian/Morphine long-acting * Naloxone * Naloxone kit 3. All patients who arrive at the emergency department with the following impatient discharge diagnosis: * Opioid use disorder (mild/moderate/severe, abuse/dependence), or opioid-related disorders * Adverse effect, and poisoning by polysubstance use * Opioid intoxication or withdrawal * Intoxication or withdrawal (from any substance, including unspecified ones) * Adverse effect, and poisoning by opioids, benzodiazepines, other antiepileptic and sedative-hypnotic drugs, and unspecified drugs * Any psychoactive substance abuse resulting in intoxication, withdrawal, or any adverse effects
💊

What it tests

  • Not listed
📍

Where

1 site
Vancouver General Hospital
Vancouver, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy